ArticleFrontiers in artificial intelligence2026
ResNet50-SCPA-net for liver cirrhosis stage classification using MRI images.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Liver cirrhosis is a chronic liver disease that develops in different stages and may cause serious complications if not diagnosed early. However, identifying the stage of liver cirrhosis from MRI images is difficult because the appearance of the liver changes as the disease progresses. Methods: In this study, a modified ResNet50-based model, called ResNet50-SCPA-Net, was developed for liver cirrhosis stage classification using liver MRI images. The proposed model combined SE channel attention and CBAM spatial attention in a parallel structure to refine the extracted features. A learnable fusion parameter was used to combine the attention features during training. To evaluate the proposed framework, a comparative analysis, an ablation study, and 5-fold cross-validation were performed. Grad-CAM visualization was applied to identify the image regions involved in the prediction process. Results: The experimental results showed that the proposed model achieved an accuracy of 80.82%, a balanced accuracy of 81.93%, an F1-score of 82.55%, and an AUC of 93.05%. The 5-fold cross-validation produced a mean accuracy of 71.54%, balanced accuracy of 73.57%, and F1-score of 73.13%. Conclusion: Overall, the findings suggest that the proposed framework can be used to automate liver cirrhosis stage classification from MRI images. Future studies should focus on larger datasets and additional imaging modalities for further evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.